ParkinsonNet has receives a Parel award by The Economic Board. ParkinsonNet aims to improve the lives of people affected by Parkinson. The Parel award goes to companies and organizations that distinguish themselves through innovation, and aims to raise awareness for them.Together with 3000 health care professionals, ParkinsonNet aims to improves life for people affected by Parkinson. "Through innovative technology en specialized treatment, we can educate patients", says Bas Bloem, professor of neurological movement disorders at Radboudumc, researcher at the Donders Institute, and co-founder of ParkinsonNet.
The results achieved by ParkinsonNet did not go unnoticed outside of the Netherlands: several networks have come into existence around the organization. Moreover, it has begun to cooperate with the life science company Verily.
"We are very happy with the Parel award, as it reflects recognition for the economical value of ParkinsonNet by a third, unrelated party. That is not our goal, but it furthers our ambition to help people across the globe and to foster collaboration with private parties."
The Parel award and The Economic Board
Started in 2016, this has been the second time that the Parel awards were awarded by The Economic Board. This year it was also awarded to Kraft Heinz and Allego. The Parel award distinguishes companies and organizations that, in the view of The Economic Board, excel through innovation.
The Economic Board is a Triple Helix collaboration between the state, research institutes, and private companies in the region Arnhem - Nijmegen and the city of Wageningen. This part of the Netherlands is considered a bulwark for food, health care, energy, and the corresponding state-of-the-art research. It is the intent of The Economic Board to communicate the potential of this region and to bring together entrepeneurs, investors, education, research, and the state.
Related news items
Ivan Zhovannik receives best presenter award at MISP25 June 2019
Ivan Zhovannik was awarded the best presenter award at the MISP 2019 (Medical Imaging Symposium for PhD students) held in Groningen.read more
Cost-effectiveness of mpMRI in active surveillance of prostate cancer25 June 2019
In European Urology Oncology Sejal Patel and colleagues evaluated the potential cost-effectiveness of including mpMRI in active surveillance for men diagnosed with low-risk prostate cancer in comparison to the standard monitoring program.read more
The gap in mortality between older and younger CRC patients has been bridged25 June 2019
In European Journal of Cancer, Nelleke Brouwer, Thea Zonneveld-Heil and colleagues showed that differences in postoperative mortality between older and younger patients with stage I-III colorectal cancer decreased. 1-year postoperative RS was almost equal for older and younger patients in 2015-2016.read more
Surgery to straighten a deviated septum improves quality of life20 June 2019
Patients with a deviated septum breathe more easily after a septoplasty and their quality of life improves. Specialists have long debated its benefits. Machteld van Egmond, Maroeska Rovers, and Niels van Heerbeek have ended the controversy with a publication in The Lancet.read more
A personal touch of Jaap ten Oever20 June 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Jaap ten Oever.read more
Development of nationwide recommendations to support prenatal counseling in extreme prematurity20 June 2019
In Pediatrics Rosa Geurtzen et al described the development of a nationwide, evidence-based framework for prenatal counseling in extreme prematurity. It contains recommendations and tools for personalization in the domains of organization, decision-making, content, and style of prenatal counseling.read more